Infographic
EU Oncology Biosimilars
Oct 26, 2018

IQVIA research identified that the total EU5 oncology market grew to $25 bn in 2017, and the launch of biosimilars over the next few years will make new drugs more accessible to patients. The information is for EU5 countries (France, Germany, Italy, Spain and U.K.).

Contact Us